InvestorsHub Logo
Followers 18
Posts 2209
Boards Moderated 0
Alias Born 12/19/2019

Re: sharkey1 post# 370532

Wednesday, 06/29/2022 8:37:29 AM

Wednesday, June 29, 2022 8:37:29 AM

Post# of 403229
Hard to say because Sabril was already being hit by generic competition in 2021 which would imply there are other generic sales that were taking 20% of their market share. It certainly beefs up Elite's drug portfolio.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News